Pfizer Cancer Drug Advances

An advisory committee to the FDA said the agency should approve Pfizer Inc.'s drug axitinib for use in patients with advanced kidney cancer.

Topics:  fda   pfizer inc   cancer   drug   
BING NEWS:
  • EC Approves NVS' Kisqali for a Broad Population in Early Breast Cancer
    Novartis NVS announced that the European Commission (“EC”) has approved its breast cancer drug Kisqali (ribociclib) for a broad population. The EC has approved Kisqali in combination with an aromatase ...
    11/28/2024 - 4:02 am | View Link
  • Gold-based drug slows cancer tumor growth by 82%, outperforms chemotherapy
    A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.
    11/27/2024 - 8:09 am | View Link
  • Diabetes drug metformin might help fight lung cancer
    Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows.
    11/26/2024 - 10:40 pm | View Link
  • Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead?
    Nobody can predict the future, but it's not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug spending in the U.S. climbed more than 8% to reach $406 billion. It's a lot but ...
    11/26/2024 - 9:31 pm | View Link
  • FDA to Review Exelixis' Application to Expand Use of Cancer Drug
    Exelixis plans to meet with the FDA's oncologic drugs advisory committee in March to discuss the drug's potential new uses. The meeting will review the safety and effectiveness of the cancer drug ...
    11/26/2024 - 10:01 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News